IMB-007

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameIMB-007
Drug Alias NameIMB007
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor modulatorsN-Type Calcium channels inhibitors
TargetsN-Type Calcium channelsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A